P. Berthaud

Prospective Multicentric Randomized Phase III Study of Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors Comparing Interruption Versus Continuation of Treatment Beyond 1 Year: The French Sarcoma Group

Jean‐Yves Blay, Axel Le Cesne, Isabelle Ray‐Coquard et al. · Journal of Clinical Oncology · 2007 · 391 citations

Medicine, Oncology, Pharmacotherapy +11

Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: A prospective study of 54 patients

Laurence Valeyrie, Sylvie Bastuji‐Garin, J. Revuz et al. · Journal of the American Academy of Dermatology · 2003 · 231 citations

Medicine, Hematology, Oncology +13

Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL-6 and MMP-1 by the Tumoral Environment

Sophie Derenne, Martine Amiot, Sophie Barillé‐Nion et al. · Journal of Bone and Mineral Research · 1999 · 197 citations · Full text

Medicine, Oncology, Pharmacology +14

Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors

Catherine Delbaldo, Étienne Chatelut, Micheline Ré et al. · Clinical Cancer Research · 2006 · 161 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study

André Delannoy, Éric Delabesse, Véronique Lhéritier et al. · Leukemia · 2006 · 113 citations

Medicine, Oncology, Pharmacotherapy +15